Growing Prevalence of Treatment-Resistant Depression to Drive The global Treatment Resistant Depression Market Growth

Lucy Kart

Growing Prevalence of Treatment-Resistant Depression to Drive The global Treatment Resistant Depression Market Growth

Treatment-resistant depression (TRD), also known as treatment-resistant major depressive disorder, is a condition where a person's major depressive disorder (MDD) does not respond adequately to antidepressant medication and/or psychotherapy. Individuals suffering from TRD experience impairing symptoms of depression for extended durations despite receiving treatments. Some of the common symptoms seen in TRD patients include difficulty concentrating, lack of energy, feelings of worthlessness, sleep issues and recurrent thoughts of death or suicide. Both psychotherapy and antidepressant medications are prescribed to reduce TRD symptoms and help patients manage their depression.

The global Treatment Resistant Depression Market is estimated to be valued at US$ 1220.12 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Growth in TRD disease prevalence has accelerated the treatment resistant depression market trends over the last few years. According to a recent study, an estimated 5-10% of individuals suffering from MDD exhibit TRD. This high number of TRD cases is attributed to factors like early age of onset of depression, duration of the depressive episode and severity of symptoms. Rising awareness about available treatment options and their effectiveness in managing TRD is also contributing to the steady market growth.

Segment Analysis

Treatment Resistant Depression (TRD) consists of two major segments viz, Drugs and Therapy. Among these, Drugs segment is projected to dominate the market with highest market share during the forecast period. Within drugs segment, first line and second line antidepressant drugs hold substantial share with first line drugs being the dominating sub-segment currently. This is because first line antidepressant drugs like selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are preferred as first line treatment for TRD owing to their better safety and tolerability profile.

Key Takeaways

Global Treatment Resistant Depression Market Demand is expected to witness high growth. The market in North America currently dominates the global market and is expected to continue its dominance during the forecast period of 2023-2030. This is owing to the high prevalence of psychiatric disorders, rising awareness about treatment options for TRD, and availability of advanced healthcare facilities in the region.

Regional analysis

North America is projected to be the fastest growing regional market for Treatment Resistant Depression treatment over the forecast period. According to National Institute of Mental Health, around 16 million adults in the US had at least one major depressive episode in 2019. Along with high prevalence, other factors such as favorable reimbursement policies, growing usage of direct-to-consumer genetic tests, strong government support and increasing focus on R&D of advanced therapeutics will spur the growth of TRD market in the region.

Key players

Key players operating in the Treatment Resistant Depression market are AbbVie Inc., Eli Lilly and Company, GlaxoSmithKline Plc., Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Viatris Inc., Otsuka Holdings Co., Ltd., H. Lundbeck A/S, AstraZeneca, and Aurobindo Pharma Ltd.

Get More Insights on this Topic https://www.rapidwebwire.com/treatment-resistant-depression-market-forecast-value-insights-and-forecast/

Lucy Kart

Treatment Resistant Depression Is Estimated To Witness High Growth Owing To Novel Treatment Approaches

kiran gire 2024-01-16

The ongoing research in novel treatment approaches like transcranial magnetic stimulation, electroconvulsive therapy, ketamine infusions and vagus nerve stimulation is fueling significant growth in the treatment resistant depression market. The global Treatment Resistant Depression Market is estimated to be valued at US$ 1220. Its adoption would drive significant revenues in the global treatment resistant depression market during the forecast period. Bargaining power of buyers: The bargaining power of buyers is moderate as treatment resistant depression has few therapeutic alternatives. Key Takeaways The global treatment resistant depression market scope is expected to witness high growth supported by rising prevalence, growing mental health funding and robust drug development pipelines.

Treatment Resistant Depression Market Is Estimated To Witness High Growth Owing To the Increasing Prevalence of Treatment-Resistant Depression

Gauri Cmi 2023-09-18

The global Treatment Resistant Depression Market is estimated to be valued at US$ 1,180. The increasing prevalence of treatment-resistant depression and the need for alternative treatment options are driving the growth of this market. Economic: Economic factors such as healthcare spending, insurance coverage, and affordability of treatment play a crucial role in the treatment resistant depression market. Technological: Technological advancements in the field of psychiatry and neuroscience are driving innovation in the treatment resistant depression market. Key Takeaways: The global treatment resistant depression market is expected to witness high growth, exhibiting a CAGR of 3.

Treatment Resistant Depression Market Current Industry Status, Business Outlook and Key Regions 2027

Anjali Pawar 2023-04-11

The TRD market is growing rapidly, driven by the increasing prevalence of depression and the rising demand for new treatment options. The market can be analyzed based on geographical regions, with North America being the largest market, followed by Europe The TRD market can be analyzed based on geographical regions. Some of the key regions in the TRD market are:North America: North America is the largest Treatment Resistant Depression Market, accounting for the majority of the global market share. The market in Europe is driven by the increasing prevalence of depression and the rising demand for new treatment options. Asia Pacific: The TRD market in Asia Pacific is expected to grow at a significant rate over the next few years.

Treatment Resistant Depression Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Depression

Anjali CMI 2023-10-19

The global Treatment Resistant Depression Market is estimated to be valued at US$ 1,180. PEST Analysis:Political: The political factors affecting the treatment resistant depression market include government regulations and policies related to pharmaceuticals and mental health. Social: Social factors play a significant role in the treatment resistant depression market. Technological: Technological advancements in the field of mental health research and treatment contribute to the growth of the treatment resistant depression market. In terms of regional analysis, North America is the fastest growing and dominating region in the treatment resistant depression market.

Global Treatment-Resistant Depression Treatment Market 2022 - Top Key Players Analysis Report Till 2028

Anisha Rathore 2023-04-08

COVID-19 Impact Analysis on Treatment-Resistant Depression Treatment Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2028. The major players in the treatment-resistant depression treatment market include Eli Lilly and Company, GlaxoSmithKline, Pfizer Inc. Get more information on "Global Treatment-Resistant Depression Treatment Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Treatment-Resistant Depression Treatment Market Research Report with detailed TOC at https://www. Purchase Complete Global Treatment-Resistant Depression Treatment Market Research Report at https://www.

Treatment-Resistant Depression Treatment Market: R&D Consistency Drives Sector Growth

Ganesh Shinde 2023-01-04

The global Treatment-Resistant Depression Treatment Market size is expected to be valued at US$ 1. FMI, in its upcoming business report, elaborates the historical and current scenario of the global Treatment-Resistant Depression Treatment Market in terms of production, consumption, volume, and value. Consequently, the impact is noticeable in the Treatment-Resistant Depression Treatment market. The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Treatment-Resistant Depression Treatment market. com/reports/treatment-resistant-depression-treatment-marketTreatment-Resistant Depression Treatment Market: SegmentationValuable information covered in the FMI’s Treatment-Resistant Depression Treatment market report has been segregated into key segments and sub-segments.

WHO TO FOLLOW

MORE FROM AUTHOR

Open source CRM software: Short Summary

Lucy Kart 2024-03-26

Next Generation Probiotics: Rising Significance of Health and Wellness

Lucy Kart 2024-03-22

Shavers - An Essential Grooming Tool

Lucy Kart 2024-03-22

The Rapid Rise of Europe E-bikes

Lucy Kart 2024-03-20

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

The Availability Of Various Depression Drugs Makes It Easier For Individuals To Choose The Right Drug For Their Symptoms And Needs

Pooja salve 2022-12-01

Eventually, between 80% and 90% of depressed individuals respond well to therapy. An individual's brain chemistry may contribute to their depression and may influence how they are treated. If a Depression Drugs does not work as expected or if you experience any side effects, you should inform your doctor right away. After symptoms have improved, psychiatrists typically advise patients to take their medication for another six months or longer. For some individuals at high risk, longer-term maintenance therapy may be advised to reduce the risk of subsequent episodes.

Most constipation treatment can be done at home.

Shivani 2022-02-16

You can treat mild to moderate constipation at home in the majority of situations. Self-care begins with a review of what you eat and drink, followed by modifications. Here are some Constipation Treatment to help you get rid of your constipation:Drink an extra two to four glasses of water each day. Increase your intake of fruits, vegetables, whole grains, and other high-fiber foods. Reduce your intake of high-fat foods such as meat, eggs, and cheese.

Major Depressive Disorder Treatment Market: A Comprehensive Overview

gauri kanale 2023-06-27

The Major Depressive Disorder Treatment Market is witnessing substantial growth due to the rising prevalence of depression worldwide. This market is driven by the increasing demand for effective treatment options to combat MDD. The market players are also focusing on research and development activities to introduce innovative treatment options for MDD patients. The market is expected to continue expanding as advancements in treatment options and supportive government initiatives drive further developments in this field. html

Treatment-Resistance Depression Treatment Market to Grow at a Steady CAGR, and Forecast to 2028

preet gambhir 2019-11-07

With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global treatment-resistance depression treatment market as well as the factors responsible for such a growth.

Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.We leverage space-age industrial and digitalization tools to provide avant-garde actionable insights to our clients regarding the treatment-resistance depression treatment market.

For enhancing readers’ experience, the report starts with a basic overview about the treatment-resistance depression treatment market and its classification.Competitive Assessment The treatment-resistance depression treatment market report includes global as well as emerging players:AstraZeneca plcPfizer, IncGlaxoSmithKline plcEli Lilly and CompanyBristol-Myers SquibbForest Laboratories (Allergan plc)Janssen Pharmaceuticals, IncSchering Plough CorporationVistagen Therapeutics, IncThe insights for each vendor consists of:Company profileSWOT analysisMain market informationMarket shareRevenue, pricing and gross marginRequest TOC of this Report - https://www.factmr.com/connectus/sample?flag=T_id=3147Regional Analysis Important regions covered in the treatment-resistance depression treatment market report include:North America (U.S., Canada)Latin America (Mexico.

Brazil)Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)Eastern Europe (Poland, Russia)The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)JapanThe Middle East and Africa (GCC, S. Africa, N. Africa)The treatment-resistance depression treatment market report also provides data regarding the key countries in the defined regions.Segmentation AnalysisBy Drug Class:Tricyclic Antidepressants (TCAs)Monoamine Oxidase Inhibitors (MAOIs)Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)Selective Serotonin Reuptake Inhibitors (SSRIs)Serotonin Neurotransmitter (5-HT2)-receptor AntagonistsNovel AgentsBy end use:Mental HospitalsPsychiatric ClinicsOthersWhat insights does the treatment-resistance depression treatment market report provide to the readers?Treatment-resistance depression treatment market fragmentation on the basis of product type, end use, and region.Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.Collaborations, R projects, acquisitions, and product launches of each treatment-resistance depression treatment market player.Various regulations imposed by the governments on the consumption of treatment-resistance depression treatment market in detail.Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global treatment-resistance depression treatment market.Questionnaire answered in the treatment-resistance depression treatment market report include:What is the present and future outlook of the global treatment-resistance depression treatment market on the basis of region?What are the challenges and opportunities for the treatment-resistance depression treatment market?Why the consumption of treatment-resistance depression treatment market highest in region?In which year segment is expected to overtake segment?Request Sample Report - https://www.factmr.com/connectus/sample?flag=S_id=3147And many more …

Treatment Resistant Depression Market is Estimated to Witness High Growth Owing to Growing Usage of Cannabidiol Based Pharmaceutical Drugs

Purvaja 2024-02-15

The treatment resistant depression market involves pharmaceutical drugs that are used for treating depression which does not respond to several antidepressant medications. The Global Treatment Resistant Depression Market Demand is estimated to be valued at US$ 1405. Some of the key opportunities in the treatment resistant depression market include increasing adoption of cannabidiol as an alternative treatment, growing clinical trials to prove efficacy of cannabidiol based drugs and approval of new cannabidiol pharmaceutical products. This is driving its increased adoption among doctors and patients for treatment resistant depression cases. PEST Analysis Political: The Treatment Resistant Depression market is regulated by various agencies and policies set by countries for the marketing and promotion of drugs and therapies.

The Castrate Resistant Prostate Cancer Market Growth is Accelerated by Rising Adoption of Targeted Therapy

Mia Yates 2024-01-03

The global Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11. The global castrate resistant prostate cancer market is growing due to increasing prevalence of prostate cancer and rising adoption of targeted therapy. The increasing success of targeted therapy in improving survival rates of castrate resistant prostate cancer patients is fueling its rising demand. Segment Analysis The global castrate resistant prostate cancer market is dominated by chemotherapy as a major treatment segment. Key Takeaways The Global Castrate Resistant Prostate Cancer Market Size is expected to witness high growth over the forecast period of 2023 to 2030.

Castrate Resistant Prostate Cancer Market Growth Accelerated By Emerging Biologics & Novel Combination Therapies

Leena Shedmake 2024-01-04

It is the most advanced stage of prostate cancer with limited treatment options. The global Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11. Segment Analysis The global castrate resistant prostate cancer market is dominated by novel therapies segment. This has resulted in novel therapies becoming the preferred option for treating castrate resistant prostate cancer. Regional analysis: North America is currently the dominant region for the castrate resistant prostate cancer market and is expected to maintain its dominance over the forecast period.

Thromboelastography Market Connected with Market Key Trends and Analysis

Lucy Kart 2023-10-26

The global Thromboelastography Market is estimated to be valued at US$ 604. Similarly, other players are introducing new cartridge-based systems, point-of-care devices, and software to streamline testing and analysis in the thromboelastography market. Porter's Analysis Threat of new entrants: The threat of new entrants is moderate in the thromboelastography market as the setup of production facility requires high initial investment. Competitive rivalry: The competitive rivalry is high among the key players to gain higher market share. 1% over the forecast period, due to increasing adoption of POC testing and focus on advanced coagulation monitoring.

How to Request a Mental Health Day at Work

hundal 2023-03-06

What occurs, though, if you are merely emotionally spent but are unsure of how to request a mental health day? It can be easier to decide how to request a mental health day if you are aware of what is anticipated of you in advance. When deciding how to request a mental health day, it's crucial to take into account the expected reaction of the person you need to inform. Contrary to what you may have been taught, mental health issues are just as important as physical injuries or illnesses. Plan & PracticeIt's quite clear that you're thinking ahead if you're reading a post titled "How to Ask for a Mental Health Day from Work.

The Importance of Early Diagnosis in Monkeypox Treatment

Ben Wood 2023-07-05

Identifying and diagnosing monkeypox in its early stages can significantly improve patient outcomes and reduce the risk of complications. Public awareness campaigns and education about the signs and symptoms of monkeypox treatment are essential in promoting early diagnosis. Timely recognition and diagnosis of monkeypox cases are paramount for initiating appropriate treatment and preventing its spread within communities. Over the years, researchers and healthcare professionals have been dedicated to advancing monkeypox treatment options to improve patient outcomes and prevent the spread of the disease. In this article, we will explore the latest advances in monkeypox treatment, with a particular focus on the role of Dasatinib drugs.

Healing the Soul: Innovative Approaches to Addiction Treatment

Larry Paige 2023-07-04

These approaches recognize that addiction often stems from a deep sense of spiritual disconnection and emptiness. This practice cultivates a sense of inner peace, acceptance, and connection to something greater than oneself. Another approach is adventure therapy, which utilizes outdoor activities and experiential learning to promote personal growth and self-discovery. Additionally, expressive therapies such as art therapy, music therapy, and dance/movement therapy provide creative outlets for self-expression, healing, and reconnecting with one's authentic self. Furthermore, psychedelic-assisted therapy is gaining recognition as an innovative approach.

Sarcopenia Treatment Market is Estimated to Witness High Growth

Sneha 2024-01-29

The global Sarcopenia Treatment Market is estimated to be valued at US$ 3. Key TakeawaysThe Global Sarcopenia Treatment Market Demand is expected to witness high growth over the forecast period owing to the rising geriatric population globally which is more prone to sarcopenia. Regional analysis suggests that the Asia Pacific region is expected to be the fastest growing market for sarcopenia treatment during the forecast period. Key players operating in the sarcopenia treatment market are Abbott Laboratories, Sanofi S. com/sarcopenia-treatment-market-growth-and-forecasts-analysis/ Explore more trending article related this topic - https://www.

Addiction Treatment Market to Witness Positive Growth owing to Outbreak of COVID-19, Projects Fact.MR

faisal factmr 2020-06-23

Analysis of the Global Addiction Treatment MarketA new study published by Fact.MR on the global Bupropion market includes a global analysis and opportunity assessment for the period 2020 to 2025.

The report offers a comprehensive assessment of the key market dynamics in detail.

The analysts take into account the historic as well as the current growth parameters to project the growth of the Addiction Treatment market with maximum accuracy.On the back of this, the global addiction treatment market is anticipated to expand healthily, growing 1.5X at a CAGR of 6.7% in the forecast period (2020-2025).

The report provides a Y-o-Y growth trend analysis and the current and future market volume projections (Units) for the assessment period.

The impact of the novel COVID-19 pandemic on the Addiction Treatment market is assessed in the report along with valuable insights pertaining to how market participants are adapting to the current situation.Request to View Sample of Research Report @ https://www.factmr.com/connectus/sample?flag=S_id=4712In a bid to recognize the growth prospects in the Addiction Treatment market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.

Each segment of the Addiction Treatment market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North AmericaLatin AmericaEuropeJapanAPEJMEAThe key players in the global Addiction Treatment market report consist ofAlkermesPurdue PharmaRecket Benckiser (Indivior)Orexo ABEach market player encompassed in the Addiction Treatment market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R projects, and business tactics.

Pressure Ulcers Treatment Is Fastest Growing Segment Fueling Growth Of Pressure Ulcers Treatment Market

Sumedha 2023-12-13

The Pressure Ulcers Treatment market is estimated to be valued at US$ 5247. The products used for pressure ulcers treatment include wound care dressings, wound filling iodines, diamond dressings, and other active therapy devices. Hence, growing geriatric population will augment the market growth of pressure ulcers treatment over the forecast period. Key Takeaways The Global Pressure Ulcers Treatment Market Share is expected to witness high growth, exhibiting CAGR of 6. Key playersKey players operating in the Pressure Ulcers Treatment market are Smith & Nephew PLC, Coloplast Group, ConvaTec Group PLC, B.